MediPal Holdings Corp - Company Profile
Powered by
All the data and insights you need on MediPal Holdings Corp in one report.
- Save hours of research time and resources with
our up-to-date MediPal Holdings Corp Strategy Report
- Understand MediPal Holdings Corp position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
MediPal Holdings Corp (MediPal) controls, administers and supports the operating activities of its group companies which are primarily engaged in the wholesale distribution of prescription pharmaceutical products, over-the-counter (OTC) pharmaceuticals, animal health products, cosmetics, daily necessities and food processing raw materials. The company distributes products to hospitals, prescription pharmacies, clinics, drug stores, home centers, convenience stores, supermarkets, animal hospitals, livestock clinics, livestock farms, fisheries, processed food manufactures, and others. Major subsidiaries include Mediceo Corporation, EVERLTH Co Ltd, ATOL Co Ltd, PALTAC Corporation, MP AGRO Co Ltd, Medipal Foods Co Ltd and EVERLTH Audi S Co Ltd. MediPal delivers products through distribution centers spread across Japan. MediPal is headquartered in Chuo-ku, Tokyo, Japan.
MediPal Holdings Corp premium industry data and analytics
Products and Services
Services |
---|
Wholesale Distribution |
Cosmetics |
Clinical Diagnostics |
XYZ |
XYZ |
XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
Year | Event | Description |
---|---|---|
2024 | New Products/Services | In January, the company introduced the website Rare Disease Insights for Everyone. |
2023 | Contracts/Agreements | In September, MEDICEO CORPORATION and SHINYEI Technology Co. developed a system to find abnormalities in material handling equipment. |
2023 | Contracts/Agreements | In September, the company concluded two agreements on JR-446 using JCR's proprietary J-Brain Cargo technology, for the treatment of Mucopolysaccharidosis Type IIIB. |
Competitor Comparison
Key Parameters | MediPal Holdings Corp | Cencora Inc | Cardinal Health Inc | Suzuken Co Ltd | Toho Holdings Co Ltd |
---|---|---|---|---|---|
Headquarters | Japan | United States of America | United States of America | Japan | Japan |
City | Chuo-Ku | Conshohocken | Dublin | Nagoya-Shi | Setagaya-Ku |
State/Province | Tokyo | Pennsylvania | Ohio | Aichi | Tokyo |
No. of Employees | 12,795 | 42,000 | 48,000 | 13,429 | 7,699 |
Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
Name | Position | Board | Since | Age |
---|---|---|---|---|
Shuichi Watanabe | Chief Executive Officer; Director; President | Executive Board | 2012 | 71 |
Yuji Sakon | General Manager of Administration Division; Director | Executive Board | 2012 | 69 |
Seiichi Kasuya | Director; Chief Operating Officer | Executive Board | 2019 | 60 |
Koichi Mimura | Director | Executive Board | 2021 | 66 |
Nagafuku Yasuhiro | Director; Vice President - Pharmaceutical sales | Executive Board | 2019 | 69 |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward